Loading ...

etoposide-charged nanocapsules

Based on

1 Patents
2010 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

Labrafac WL 1349® solution of etoposide

Type Complex Compound
Formula
Role core
2

Lipoid S75-3®

Type Complex Compound
Formula
Role layer
3

Solutol®-HS15

Type Polymer
Formula
Role layer

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • Lipoid S75-3®
  • Labrafac WL 1349
  • 4'-demethylepipodophyllotoxin 9-[4,6-O-(R)-ethylidene-β-D-glucopyranoside]
See all (4)
  1. 4FPfjKcngV1L0l8k
  2. u5p9lzNi0nSPGNI
  3. Itb1jlC
Product

etoposide-charged nanocapsules

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial